Marco de Morpurgo
Marco de Morpurgo focuses on government regulation of the Life Sciences industry. He helps companies doing business in the EU navigate the complex regulatory structures governing the sector, counseling such clients on regulatory strategies and compliance matters. He has extensive experience in the EU and national regulatory law and practice. Most of his work is multi-jurisdictional and he has broad experience assisting clients manage regulatory divergence within the EU and globally. Marco's practice covers the regulation of pharmaceuticals, biotechnologies, medical devices, food and beverages, and other health-related regulated products. He provides strategic advice on a broad range of regulatory issues, …
Marco de Morpurgo focuses on government regulation of the Life Sciences industry. He helps companies doing business in the EU navigate the complex regulatory structures governing the sector, counseling such clients on regulatory strategies and compliance matters.
He has extensive experience in the EU and national regulatory law and practice. Most of his work is multi-jurisdictional and he has broad experience assisting clients manage regulatory divergence within the EU and globally.
Marco's practice covers the regulation of pharmaceuticals, biotechnologies, medical devices, food and beverages, and other health-related regulated products. He provides strategic advice on a broad range of regulatory issues, including clinical trials, product approvals, market access, promotion and advertising, post-market obligations, as well as on anti-corruption laws and industry-specific ethical and behavioral rules. He also provides regulatory support in Life Sciences transactions and intellectual property litigation.
He regularly speaks and writes on Life Sciences topics and has been an external professor at HEC Paris.
See more
He has extensive experience in the EU and national regulatory law and practice. Most of his work is multi-jurisdictional and he has broad experience assisting clients manage regulatory divergence within the EU and globally.
Marco's practice covers the regulation of pharmaceuticals, biotechnologies, medical devices, food and beverages, and other health-related regulated products. He provides strategic advice on a broad range of regulatory issues, including clinical trials, product approvals, market access, promotion and advertising, post-market obligations, as well as on anti-corruption laws and industry-specific ethical and behavioral rules. He also provides regulatory support in Life Sciences transactions and intellectual property litigation.
He regularly speaks and writes on Life Sciences topics and has been an external professor at HEC Paris.
Latest Report
